Cargando…

Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case–time control study and a nested case-control study based on the French national health insurance (SNDS) cohort

INTRODUCTION: Atopic dermatitis (AD) is a highly prevalent, chronic, inflammatory skin disease. Several orally administered Janus kinase inhibitors (JAKis, including baricitinib, upadacitinib and abrocitinib) have received a marketing authorisation for AD. Clinical trials in rheumatoid arthritis (RA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berthe, Pauline, Scailteux, Lucie-Marie, Lescoat, Alain, Staumont, Delphine, Coiffier, Guillaume, Guéret, Pierre, Dupuy, Alain, Oger, Emmanuel, Droitcourt, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494565/ https://www.ncbi.nlm.nih.gov/pubmed/36130766 http://dx.doi.org/10.1136/bmjopen-2021-059979

Ejemplares similares

Effectiveness of an antenatal maternal supplementation with prebiotics for preventing atopic dermatitis in high-risk children (the PREGRALL study): protocol for a randomised controlled trial
por: Cabridain, Clémentine, et al.
Publicado: (2019)

A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial – the PRADA trial
por: Droitcourt, Catherine, et al.
Publicado: (2019)

Epidemiology of atopic dermatitis in Europe
por: Kowalska-Olędzka, Elżbieta, et al.
Publicado: (2019)

Management of Atopic Dermatitis: The Role of Tacrolimus
por: Umar, Badar Uddin, et al.
Publicado: (2022)

The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support
por: STAUMONT-SALLÉ, Delphine, et al.
Publicado: (2021)

Dermatology for the internist: optimal diagnosis and management of atopic dermatitis
por: Narla, Shanthi, et al.
Publicado: (2021)

Safety of topical corticosteroids in atopic eczema: an umbrella review
por: Axon, Emma, et al.
Publicado: (2021)

Relationship Between Atopic Dermatitis and Food Allergy in Children
por: Mehta, Yash, et al.
Publicado: (2022)

Thyroid Autoimmunity in Vitiligo: A Case-Control Study
por: Prashant, Praveen, et al.
Publicado: (2023)

Dupilumab-Associated Head and Neck Dermatitis With Ocular Involvement in a Ten-Year-Old With Atopic Dermatitis: A Case Report and Review of the Literature
por: Samia, Arthur M, et al.
Publicado: (2022)

Efficacy of the integrative Body–Mind–Spirit group intervention for improving quality of life in parent–child dyads adjusting to atopic dermatitis: protocol for a randomised controlled trial
por: Hui, Victoria Ka Ying, et al.
Publicado: (2022)

Exacerbation of Atopic Dermatitis Associated with Ustekinumab Treatment in Crohn's Disease
por: Andres, Brendan, et al.
Publicado: (2022)

Eczema and subsequent suicide: a matched case–control study
por: Drucker, Aaron Mark, et al.
Publicado: (2018)

Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
por: Johar, Reshale A, et al.
Publicado: (2023)

Epidemiology and management of atopic dermatitis in England: an observational cohort study protocol
por: de Lusignan, Simon, et al.
Publicado: (2020)

Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
por: Tameez Ud Din, Ahsan, et al.
Publicado: (2020)

Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis
por: Dewi, Dian Andriani Ratna, et al.
Publicado: (2023)

The Relationship Between Nutritional Anemia and Acne: A Case-Control Study
por: Alharbi, Norah M, et al.
Publicado: (2023)

Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure
por: Kasai, Hiroko, et al.
Publicado: (2021)

Preventive Antenatal Educational Program on Allergic Diseases (PAEPAD) versus standard antenatal care for prevention of atopic dermatitis: study protocol for a single-centre, investigator-blinded randomised controlled trial
por: Zhao, Mutong, et al.
Publicado: (2022)

Review of Prominent Cytokines as Superior Therapeutic Targets for Moderate-to-Severe Atopic Dermatitis
por: Hassan, Zaira, et al.
Publicado: (2020)

The Cross-Talk Between Atopic Dermatitis and Diabetes Mellitus: A Meta-Analysis
por: Mirghani, Hyder O, et al.
Publicado: (2021)

Assessment and Management of Atopic Dermatitis in Primary Care Settings: A Systematic Review
por: Alqahtani, Saad M, et al.
Publicado: (2023)

PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy
por: Lowe, Adrian, et al.
Publicado: (2019)

Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial
por: Jabbar-Lopez, Zarif K, et al.
Publicado: (2019)

Effect of treatments on skin microbiota in patients with atopic dermatitis: a protocol for systematic review
por: Guo, Yang, et al.
Publicado: (2022)

Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
por: Drucker, Aaron Mark, et al.
Publicado: (2018)

Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?
por: Kauhl, Winfried, et al.
Publicado: (2021)

Underlying Immune Mechanisms Involved in Cow’s Milk-Induced Hypersensitivity Reactions Manifesting as Atopic Dermatitis
por: Weimer, Derek S, et al.
Publicado: (2022)

Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment
por: Thomas, Caitlin, et al.
Publicado: (2022)

Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study
por: Hedderson, Monique M, et al.
Publicado: (2023)

Young adults’ perceptions of living with atopic dermatitis in relation to the concept of self-management: a qualitative study
por: Lundin, Susanne, et al.
Publicado: (2021)

Development of Café-Au-Lait-Macule Lesions in a Patient After Dupilumab Therapy for Atopic Dermatitis
por: Hasanain, Afnan, et al.
Publicado: (2023)

Comparison of treatment standards in Atopic Dermatitis management across selected geographies prior to emerging targeted therapies onset
por: Kowalska-Olędzka, Elżbieta, et al.
Publicado: (2019)

Knowledge mobilisation: an ethnographic study of the influence of practitioner mindlines on atopic eczema self-management in primary care in the UK
por: Cowdell, Fiona
Publicado: (2019)

Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol
por: Marín-Candón, Alicia, et al.
Publicado: (2023)

Screening for Comorbid Cardiovascular Risk Factors in Pediatric Psoriasis Among Iraqi Patients: A Case-Control Study
por: Dhaher, Samer A, et al.
Publicado: (2021)

Recent Clinical Studies on the Effects of Tumor Necrosis Factor-Alpha (TNF-α) and Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) Antibody Therapies in Refractory Cutaneous Sarcoidosis: A Systematic Review
por: Toriola, Stacy L, et al.
Publicado: (2023)

Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study
por: Riis, Jette Lindorff, et al.
Publicado: (2016)

‘Barrier dysfunction in Atopic newBorns studY’ (BABY): protocol of a Danish prospective birth cohort study
por: Gerner, Trine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rkh3km5usa37j824v3e1al7t2s